Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03190538

Nonalcoholic Steatohepatitis in Chinese Children

Nonalcoholic Steatohepatitis in Chinese Children: a Long Term Follow-up

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Humanity and Health Research Centre · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers

Summary

Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality. A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionThere will be no specific intervention to these paediatric NASH patient

Timeline

Start date
2017-05-01
Primary completion
2027-05-31
Completion
2028-05-31
First posted
2017-06-16
Last updated
2025-03-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03190538. Inclusion in this directory is not an endorsement.